Article
Biotechnology & Applied Microbiology
Raiza Amiling, Rachel L. Winer, Michael E. Newcomb, Pamina M. Gorbach, John Lin, Richard A. Crosby, Brian Mustanski, Lauri E. Markowitz, Elissa Meites
Summary: Gay, bisexual, and transgender individuals are disproportionately affected by HPV. The study found significant differences in HPV vaccination coverage by city, age, race/ethnicity, and gender identity. Increasing both routine and catch-up vaccination will improve coverage among MSM and transgender women.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
(2021)
Article
Immunology
Yuwei Li, Yi-Fan Lin, Xinsheng Wu, Xinyi Zhou, Tian Tian, Zhihui Guo, Leiwen Fu, Luoyao Yang, Zhen Lu, Song Fan, Yong Lu, Wujian Ke, Huachun Zou
Summary: This study evaluated the effectiveness and cost-effectiveness of HPV vaccination among MSM in China. The results showed that quadrivalent vaccines were most effective in reducing anogenital warts, while nine-valent vaccines were most effective in reducing anal cancer. Annual vaccination and appropriate adjustment of vaccine price are needed to improve cost-effectiveness.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Public, Environmental & Occupational Health
Catharine Chambers, Shelley L. Deeks, Rinku Sutradhar, Joseph Cox, Alexandra de Pokomandy, Troy Grennan, Trevor A. Hart, Gilles Lambert, David M. Moore, Daniel Grace, Ramandip Grewal, Jody Jollimore, Nathan J. Lachowsky, Ashley Mah, Rosane Nisenbaum, Gina Ogilvie, Chantal Sauvageau, Darrell H. S. Tan, Anna Yeung, Ann N. Burchell
Summary: Self-reported human papillomavirus (HPV) vaccination has limitations in terms of accuracy. This study investigated the impact of misclassification associated with self-reported vaccination on the estimates of vaccine effectiveness (VE). The results showed that bias-corrected VE estimates were relatively stable across different sensitivity values, but differed from the uncorrected estimate at lower specificity values. The study concluded that a large proportion of participants would need to erroneously report HPV vaccination in order to significantly change VE estimates.
Review
Medicine, General & Internal
Kenneth H. Mayer, LaRon Nelson, Lisa Hightow-Weidman, Matthew J. Mimiaga, Leandro Mena, Sari Reisner, Demetre Daskalakis, Steven A. Safren, Chris Beyrer, Patrick S. Sullivan
Summary: Men who have sex with men (MSM) in the USA face ongoing high risk of HIV acquisition, with factors including role versatility, biological, individual, social, and structural elements affecting the epidemic. Racial and ethnic minority men may be further concentrated in high-prevalence networks due to assortative mixing and adverse life experiences. Young MSM have additional HIV risks due to impulse control issues and lack of familiarity with serostatus discussions, while digital technologies could be beneficial for prevention efforts. Older and transgender MSM also face unique challenges requiring tailored HIV prevention information and culturally responsive programmes. Training of healthcare providers in culturally competent care is essential for optimizing HIV care and prevention.
Article
Public, Environmental & Occupational Health
Justin Naidu, Andrea N. N. Polonijo
Summary: This study investigates barriers and facilitators to HPV and meningococcal vaccination among MSM in a medically underserved region in the US. The key barriers to vaccination include limited awareness and knowledge, reliance on healthcare providers, stigma, uncertainty about insurance coverage and costs, and accessibility issues. Key facilitators include vaccine confidence, perceived severity of diseases, integrating vaccination into routine healthcare, and utilizing pharmacies as vaccination sites.
Article
Immunology
Rachel L. Winer, John Lin, Troy D. Querec, Elizabeth R. Unger, Joshua E. Stern, Jessica M. Rudd, Matthew R. Golden, Fred Swanson, Lauri E. Markowitz, Elissa Meites
Summary: A study found that among men who have sex with men, those who reported receiving the HPV vaccine before the age of 18 had a lower prevalence of penile HPV infection. This suggests that HPV vaccination is effective in preventing penile HPV infections in young men who have sex with men.
JOURNAL OF INFECTIOUS DISEASES
(2022)
Article
Gastroenterology & Hepatology
Daisuke Mizushima, Misao Takano, Takahiro Aoki, Naokatsu Ando, Haruka Uemura, Yasuaki Yanagawa, Koji Watanabe, Hiroyuki Gatanaga, Yoshimi Kikuchi, Shinichi Oka
Summary: The study evaluated the incidence of HBV infection among MSM and the effectiveness of tenofovir-based PrEP in preventing HBV infection. The results showed that the use of PrEP significantly reduced the rate of HBV infection among MSM, but individuals using PrEP were more susceptible to other sexually transmitted infections. A separate study on MSM with HBsAb-positive and HBcAb-negative status found an HBV incidence rate of 1.8% among PrEP users. In conclusion, tenofovir-based PrEP is effective in preventing HBV infection among MSM.
Review
Medicine, General & Internal
Wilson M. Compton, Christopher M. Jones
Summary: Among men who have sex with men, bisexual men have a higher rate of substance use compared to other subgroups, and methamphetamine use is associated with high-risk sexual behaviors and HIV transmission.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Infectious Diseases
Duo Shan, Zhen Ning, Maohe Yu, Huang Zheng, Jie Yang, Hui Gong, Jian Li, Hui Liu, Lu Liu, Vania Wang, Xiong Ran, Mengjie Han, Dapeng Zhang
Summary: Transgender women in the MSM community in China have a higher risk of acquiring HIV compared to cisgender MSM, emphasizing the need for targeted prevention measures.
INFECTIOUS DISEASES OF POVERTY
(2022)
Article
Biotechnology & Applied Microbiology
Haiying Pan, Wei He, Bing Lin, Xiaoni Zhong
Summary: This study aims to analyze the factors influencing HPV vaccination willingness among MSM in China. The findings showed that knowledge and attitude were the main factors affecting vaccination intention. Since most Chinese MSM were willing to be vaccinated against HPV, they should be included in the vaccination program and efforts should be made to enhance HPV awareness and risk awareness.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
(2022)
Review
Biotechnology & Applied Microbiology
Elissa Meites, Timothy J. Wilkin, Lauri E. Markowitz
Summary: Gay, bisexual, and other MSM and transgender women, especially those living with HIV, are disproportionately affected by HPV. Routine HPV vaccination is recommended for adolescents aged 11-12 and individuals up to age 26 in the United States, with efforts to increase vaccination coverage and monitor health impacts.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
(2022)
Article
Biotechnology & Applied Microbiology
R. Grewal, S. L. Deeks, T. A. Hart, J. Cox, A. De Pokomandy, T. Grennan, G. Lambert, D. Moore, F. Coutlee, M. Gaspar, C. George, D. Grace, J. Jollimore, N. J. Lachowsky, R. Nisenbaum, G. Ogilvie, C. Sauvageau, D. H. S. Tan, A. Yeung, A. N. Burchell
Summary: The study explored the factors associated with different stages of HPV vaccination among gay, bisexual, and other men who have sex with men in the three largest Canadian cities. It found that factors such as sexual orientation, immigrant status, preference for privacy in same-sex relationships, access to sexual health information, healthcare usage, and history of hepatitis vaccination influenced their decisions to receive the HPV vaccine. Interventions aiming to reduce barriers, increase sexual health knowledge, and improve access to GBM-competent healthcare are needed to enhance vaccine uptake among this population.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
(2021)
Article
Immunology
Wei He, Haiying Pan, Bing Lin, Xiaoni Zhong
Summary: The study found that HIV-negative MSM in China have a high willingness to receive HPV vaccination, and willingness to vaccinate is closely related to knowledge of HPV infection and vaccines, risk perception, and vaccine promotion attitude. Strengthening health education, raising awareness of HPV infection and vaccines, and promoting risk perception of HPV infection among MSM will help increase their willingness for HPV vaccination.
Article
Virology
Yuwei Li, Xin Peng, Leiwen Fu, Bingyi Wang, Yinghui Sun, Yuanyi Chen, Yi-Fan Lin, Xinsheng Wu, Qi Liu, Yanxiao Gao, Weiran Zheng, Junye Bian, Zhen Lu, Xiaojun Meng, Hui Xue, Hui Li, Hongbo Jiang, Huachun Zou
Summary: Men who have sex with men (MSM) in China have low hesitancy toward monkeypox vaccination. Factors associated with hesitancy include lack of fixed income, infrequent information following, and lack of worries about monkeypox endemic. Those who perceived a smaller proportion of HIV-infected cases, disagreed that monkeypox virus could be detected in semen, and considered certain monkeypox vaccines unsuitable for HIV-infected people were generally more hesitant. HIV-infected MSM showed more support for vaccination promotion compared to HIV-uninfected MSM. The findings emphasize the importance of safety, affordability, and information availability in reducing hesitancy and promoting future vaccination plans.
JOURNAL OF MEDICAL VIROLOGY
(2023)
Article
Medicine, General & Internal
Cedric H. Bien-Gund, Pamela A. Shaw, Christine Agnew-Brune, Amy Baugher, Kathleen A. Brady, Robert Gross
Summary: This study found that HIV self-testing (HIVST) is relatively uncommon among urban men who have sex with men (MSM) in the US. The findings suggest that HIVST may not be reaching those with lower socioeconomic status or who have not disclosed their sexual identity. Efforts to increase HIVST should focus on engaging underserved and vulnerable subgroups of MSM.
Article
Urology & Nephrology
Kiri A. Sandler, Ryan R. Cook, Jay P. Ciezki, Ashley E. Ross, Mark M. Pomerantz, Paul L. Nguyen, Talha Shaikh, Phuoc T. Tran, Richard G. Stock, Gregory S. Merrick, David Jeffrey Demanes, Daniel E. Spratt, Eyad I. Abu-Isa, Trude B. Wedde, Wolfgang Lilleby, Daniel J. Krauss, Grace K. Shaw, Ridwan Alam, Chandana A. Reddy, Daniel Y. Song, Eric A. Klein, Andrew J. Stephenson, Jeffrey J. Tosoian, John V. Hegde, Sun Mi Yoo, Ryan Fiano, Anthony V. D'Amico, Nicholas G. Nickols, William J. Aronson, Ahmad Sadeghi, Stephen C. Greco, Curtiland Deville, Todd McNutt, Theodore L. DeWeese, Robert E. Reiter, Jonathan W. Said, Michael L. Steinberg, Eric M. Horwitz, Patrick A. Kupelian, Christopher R. King, Amar U. Kishan
Article
Primary Health Care
Laura P. Hurley, Sean T. O'Leary, Lauri E. Markowitz, Lori A. Crane, Jessica R. Cataldi, Michaela Brtnikova, Brenda L. Beaty, Carol Gorman, Elissa Meites, Megan C. Lindley, Allison Kempe
Summary: The survey revealed that despite the new ACIP recommendation, physicians are interested in recommending HPV vaccination for adults aged 27 to 45 years. However, the majority of physicians require more education to better understand the optimal use of HPV vaccine in this age group.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE
(2021)
Article
Medicine, General & Internal
Mark S. Freedman, Henry Bernstein, Kevin A. Ault
ANNALS OF INTERNAL MEDICINE
(2021)
Article
Immunology
Elissa Meites, Laura Stone, Raiza Amiling, Vidisha Singh, Elizabeth R. Unger, Craig S. Derkay, Lauri E. Markowitz
Summary: Study findings suggest a significant decrease in the number of cases and incidence rates of Juvenile-onset Recurrent Respiratory Papillomatosis (JORRP) in the United States following the introduction of HPV vaccination. Data indicate that HPV vaccination plays a crucial role in reducing the incidence of JORRP.
CLINICAL INFECTIOUS DISEASES
(2021)
Article
Pediatrics
Jessica R. Cataldi, Sean T. O'Leary, Lauri E. Markowitz, Mandy A. Allison, Lori A. Crane, Laura P. Hurley, Michaela Brtnikova, Brenda L. Beaty, Carol Gorman, Elissa Meites, Megan C. Lindley, Allison Kempe
Summary: Between 2008 and 2018, more primary care physicians reported recommending HPV vaccination for adolescents, fewer reported barriers, and more physicians reported parents who had vaccine safety or moral/religious concerns.
JOURNAL OF PEDIATRICS
(2021)
Article
Infectious Diseases
Ethan Morgan, Elissa Meites, Lauri E. Markowitz, Casey D. Xavier Hall, Troy D. Querec, Elizabeth R. Unger, Richard A. Crosby, Michael E. Newcomb, Brian Mustanski
Summary: This study found that individuals who engage in anal receptive sex have a higher prevalence of any HPV infection among men who have sex with men and transgender women. However, receiving the HPV vaccine can reduce the risk of infection with 4-valent HPV types regardless of sexual practices.
SEXUALLY TRANSMITTED DISEASES
(2021)
Article
Immunology
Rachel L. Winer, John Lin, Troy D. Querec, Elizabeth R. Unger, Joshua E. Stern, Jessica M. Rudd, Matthew R. Golden, Fred Swanson, Lauri E. Markowitz, Elissa Meites
Summary: A study found that among men who have sex with men, those who reported receiving the HPV vaccine before the age of 18 had a lower prevalence of penile HPV infection. This suggests that HPV vaccination is effective in preventing penile HPV infections in young men who have sex with men.
JOURNAL OF INFECTIOUS DISEASES
(2022)
Article
Infectious Diseases
Terra Forward, Elissa Meites, John Lin, James P. Hughes, Elizabeth R. Unger, Lauri E. Markowitz, Matthew Golden, Fred Swanson, Paul M. Faestel, Rachel L. Winer
Summary: This study assessed the self-reported sensitivity of HPV vaccination among young adult men who have sex with men. The results showed that most participants with documented HPV vaccination history accurately self-reported their vaccination status. However, the accuracy of recall decreased over time since the first dose of vaccination.
SEXUALLY TRANSMITTED DISEASES
(2022)
Article
Immunology
Feixue Wei, Michael M. Gaisa, Gypsyamber D'Souza, Ningshao Xia, Anna R. Giuliano, Stephen E. Hawes, Lei Gao, Shu-Hsing Cheng, Maria Gabriella Dona, Stephen E. Goldstone, Maarten F. Schim van der Loeff, Karin Neukam, Elissa Meites, I. Mary Poynten, Jianghong Dai, Jean-Damien Combes, Ulrike Wieland, Joaquin Burgos, Timothy J. Wilkin, Alexandra L. Hernandez, Mauricio Iribarren Diaz, Carmen Hidalgo-Tenorio, Marleny Valencia Arredondo, Alan G. Nyitray, Nicolas Wentzensen, Eric Pf Chow, Vitaly Smelov, Rebecca G. Nowak, Nittaya Phanuphak, Yin Ling Woo, Yoojin Choi, Yifei Hu, Alice M. Schofield, Petra J. Woestenberg, Admire T. Chikandiwa, Andrew C. Hickey, Alexandra de Pokomandy, Gad Murenzi, Helene Pere, Marta del Pino, Ana P. Ortiz, Angella Charnot-Katsikas, Xing Liu, Suwat Chariyalertsak, Carol Strong, Jason J. Ong, Evy Yunihastuti, Isabelle Etienney, Valentine M. Ferre, Huachun Zou, Michel Segondy, Simbarashe Chinyowa, Catharina J. Alberts, Gary M. Clifford
Summary: The study evaluated the age-specific prevalence of anal HPV and HSIL in men, stratified by HIV status and sexuality, highlighting the importance of gender-neutral HPV vaccination and anal cancer screening research for high-risk populations.
Article
Public, Environmental & Occupational Health
Elissa Meites, Kristina L. Bajema, Anita Kambhampati, Mila Prill, Vincent C. Marconi, Sheldon T. Brown, Maria C. Rodriguez-Barradas, David O. Beenhouwer, Mark Holodniy, Cynthia Lucero-Obusan, Cristina Cardemil, Jordan Cates, Diya Surie
Summary: Early in the COVID-19 pandemic, the CDC used existing hospital networks for surveillance. The SUPERNOVA platform adapted for COVID-19 surveillance provided important data on disease burden and outcomes. Participants with COVID-19 had higher risk of adverse outcomes compared to controls, highlighting the importance of surveillance data in public health emergencies.
FRONTIERS IN PUBLIC HEALTH
(2021)
Review
Biotechnology & Applied Microbiology
Elissa Meites, Timothy J. Wilkin, Lauri E. Markowitz
Summary: Gay, bisexual, and other MSM and transgender women, especially those living with HIV, are disproportionately affected by HPV. Routine HPV vaccination is recommended for adolescents aged 11-12 and individuals up to age 26 in the United States, with efforts to increase vaccination coverage and monitor health impacts.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
(2022)
Article
Public, Environmental & Occupational Health
Elissa Meites, Martha Knuth, Kaely Hall, Patrick Dawson, Teresa W. Wang, Marcienne Wright, Wei Yu, Schabbethai Senesie, Elizabeth Stephenson, Chukwuebuka Imachukwu, Takudzwa Sayi, Brian Gurbaxani, Erik R. Svendsen, Muin J. Khoury, Barbara Ellis, Brian A. King
Summary: The Centers for Disease Control and Prevention (CDC) has made significant contributions to scientific publications during the COVID-19 pandemic. They have published numerous articles in areas such as testing, prevention strategies, vaccines, and health equity, and have adapted to address new scientific questions.
PUBLIC HEALTH REPORTS
(2023)
Article
Immunology
Courtney A. Gidengil, Andrew M. Parker, Lauri E. Markowitz, Amber M. Gedlinske, Natoshia M. Askelson, Christine A. Petersen, Elissa Meites, Megan C. Lindley, Aaron M. Scherer
Summary: This survey aimed to understand physician knowledge, attitudes, and practices regarding HPV vaccination for adults aged 27-45 years. The results showed that despite the COVID-19 pandemic, at least a third of participating physicians in each practice specialty reported having more HPV vaccine shared clinical decision-making (SCDM) discussions with patients in the past 12 months. However, although the majority of physicians were aware of the SCDM recommendation for this age group, only half of them answered an objective knowledge question correctly.
Article
Biotechnology & Applied Microbiology
Raiza Amiling, Rachel L. Winer, Michael E. Newcomb, Pamina M. Gorbach, John Lin, Richard A. Crosby, Brian Mustanski, Lauri E. Markowitz, Elissa Meites
Summary: Gay, bisexual, and transgender individuals are disproportionately affected by HPV. The study found significant differences in HPV vaccination coverage by city, age, race/ethnicity, and gender identity. Increasing both routine and catch-up vaccination will improve coverage among MSM and transgender women.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
(2021)
Article
Infectious Diseases
Raiza Amiling, Elissa Meites, Troy D. Querec, Laura Stone, Vidisha Singh, Elizabeth R. Unger, Craig S. Derkay, Lauri E. Markowitz
Summary: This study found that children with JORRP were commonly firstborn, delivered vaginally to young mothers, and most of the mothers reported no HPV vaccination before delivery. Disease severity was associated with younger diagnosis age and detection of HPV type 11.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY
(2021)
